Retrospective Study of the Biomechanical Properties of Large Allografts
Terminated
- Conditions
- Bone Cancer
- Interventions
- Procedure: Tissue Sample
- First Posted Date
- 2008-03-10
- Last Posted Date
- 2012-08-01
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 2
- Registration Number
- NCT00632294
- Locations
- 🇺🇸
U.T.M.D. Anderson Cancer Center, Houston, Texas, United States
Lenalidomide in Chronic Lymphocytic Leukemia (CLL) Patients With Residual Disease
- First Posted Date
- 2008-03-10
- Last Posted Date
- 2020-02-10
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 33
- Registration Number
- NCT00632359
- Locations
- 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Screening for Familial Colorectal Cancer (CRC) Patients
Completed
- Conditions
- Colorectal Cancer
- Interventions
- Behavioral: Questionnaire
- First Posted Date
- 2008-03-10
- Last Posted Date
- 2020-06-16
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 269
- Registration Number
- NCT00632515
- Locations
- 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Sunitinib Malate, Hormone Ablation and Radiation Therapy in Patients With Prostate Cancer
Phase 1
Completed
- Conditions
- Prostate Cancer
- Interventions
- First Posted Date
- 2008-03-07
- Last Posted Date
- 2015-01-29
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 19
- Registration Number
- NCT00631527
- Locations
- 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Analysis of Parametrial Lymph Nodes as Sentinel Nodes in Patients With Cervical Cancer
Not Applicable
Completed
- Conditions
- Cervical Cancer
- Interventions
- Procedure: Single Photon Emission Computed TomographyProcedure: Intraoperative Lymphatic Mapping
- First Posted Date
- 2008-03-07
- Last Posted Date
- 2016-05-02
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 20
- Registration Number
- NCT00631241
- Locations
- 🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States
Sodium Stibogluconate With Interferon Alpha-2b for Patients With Advanced Malignancies
Phase 1
Completed
- Conditions
- Advanced CancerSolid Tumors
- Interventions
- First Posted Date
- 2008-03-05
- Last Posted Date
- 2018-11-15
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 33
- Registration Number
- NCT00629200
- Locations
- 🇺🇸
U.T.M.D. Anderson Cancer Center, Houston, Texas, United States
🇺🇸University of New Mexico, Albuquerque, New Mexico, United States
Rasburicase in Patients at Risk for Tumor Lysis Syndrome
Phase 2
Completed
- Conditions
- Tumor Lysis Syndrome
- Interventions
- First Posted Date
- 2008-03-05
- Last Posted Date
- 2013-08-01
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 82
- Registration Number
- NCT00628628
- Locations
- 🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States
Bevacizumab and Paclitaxel for Neuroendocrine Tumors of the Cervix
Phase 2
Terminated
- Conditions
- Cervical CancerUterine Cancer
- Interventions
- First Posted Date
- 2008-02-29
- Last Posted Date
- 2014-07-07
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 4
- Registration Number
- NCT00626561
- Locations
- 🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States
Multimodal Treatment Strategy for Cancer Cachexia
Not Applicable
Terminated
- Conditions
- CachexiaAdvanced Cancer
- Interventions
- Behavioral: Graded Resistance TrainingBehavioral: Aerobic ExerciseDietary Supplement: Juven
- First Posted Date
- 2008-02-28
- Last Posted Date
- 2016-02-12
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 15
- Registration Number
- NCT00625742
- Locations
- 🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States
Interactive Voice Response System in Advanced Cancer Patients
Not Applicable
Completed
- Conditions
- Advanced Cancer
- Interventions
- Other: Standard CareBehavioral: Interactive Voice Response System
- First Posted Date
- 2008-02-28
- Last Posted Date
- 2023-09-21
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 136
- Registration Number
- NCT00625638
- Locations
- 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath